Thalassemia in Iran: epidemiology, prevention, and management H Abolghasemi, A Amid, S Zeinali, MH Radfar, P Eshghi, MS Rahiminejad, ... Journal of Pediatric Hematology/Oncology 29 (4), 233-238, 2007 | 359 | 2007 |
Rare coagulation disorders F Peyvandi, PM Mannucci Thrombosis and haemostasis 82 (10), 1207-1214, 1999 | 236 | 1999 |
Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases A Fallah, A Sadeghinia, H Kahroba, A Samadi, HR Heidari, B Bradaran, ... Biomedicine & Pharmacotherapy 110, 775-785, 2019 | 230 | 2019 |
Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families R Harripaul, N Vasli, A Mikhailov, MA Rafiq, K Mittal, C Windpassinger, ... Molecular psychiatry 23 (4), 973-984, 2018 | 186 | 2018 |
Heterogeneity of hemoglobin H disease in childhood A Lal, ML Goldrich, DA Haines, M Azimi, ST Singer, EP Vichinsky New England Journal of Medicine 364 (8), 710-718, 2011 | 184 | 2011 |
Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort G Bademci, J Foster, N Mahdieh, M Bonyadi, D Duman, FB Cengiz, ... Genetics in Medicine 18 (4), 364-371, 2016 | 158 | 2016 |
Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients Peyvandi, Mannucci, Lak, Abdoullahi, Zeinali, Sharifian British journal of haematology 102 (2), 626-628, 1998 | 156 | 1998 |
Missense mutations in the human β fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion S Duga, R Asselta, E Santagostino, S Zeinali, T Simonic, M Malcovati, ... Blood, The Journal of the American Society of Hematology 95 (4), 1336-1341, 2000 | 147 | 2000 |
Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor M Behdani, S Zeinali, H Khanahmad, M Karimipour, N Asadzadeh, ... Molecular immunology 50 (1-2), 35-41, 2012 | 136 | 2012 |
Genetic causes of nonsyndromic hearing loss in Iran in comparison with other populations N Mahdieh, B Rabbani, S Wiley, MT Akbari, S Zeinali Journal of human genetics 55 (10), 639-648, 2010 | 122 | 2010 |
The human CIB1–EVER1–EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses SJ De Jong, A Créquer, I Matos, D Hum, V Gunasekharan, L Lorenzo, ... The Journal of experimental medicine 215 (9), 2289, 2018 | 116 | 2018 |
Development of VEGFR2-specific Nanobody Pseudomonas exotoxin A conjugated to provide efficient inhibition of tumor cell growth M Behdani, S Zeinali, M Karimipour, H Khanahmad, S Schoonooghe, ... New biotechnology 30 (2), 205-209, 2013 | 112 | 2013 |
Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency F Peyvandi, VP Jenkins, PM Mannucci, A Billio, S Zeinali, SJ Perkins, ... Thrombosis and haemostasis 84 (08), 250-257, 2000 | 102 | 2000 |
MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines M Azizi, L Teimoori-Toolabi, MK Arzanani, K Azadmanesh, ... Cancer biology & therapy 15 (4), 419-427, 2014 | 94 | 2014 |
Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency S Akhavan, PM Mannucci, M Lak, G Mancuso, MG Mazzucconi, A Rocino, ... Thrombosis and haemostasis 84 (12), 989-997, 2000 | 90 | 2000 |
A novel GJA8 mutation in an Iranian family with progressive autosomal dominant congenital nuclear cataract CE Willoughby, S Arab, R Gandhi, S Zeinali, S Arab, D Luk, G Billingsley, ... Journal of medical genetics 40 (11), e124-e124, 2003 | 87 | 2003 |
Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods Y Gheisari, M Soleimani, K Azadmanesh, S Zeinali, Y Gheisari, ... Cytotherapy 10 (8), 815-823, 2008 | 86 | 2008 |
β-THALASSEMIA INTERMEDIA FROM SOUTHERN IRAN: IVS-II-1 (G→A) IS THE PREVALENT THALASSEMIA INTERMEDIA ALLELE M Karimi, H Yarmohammadi, S Farjadian, S Zeinali, Z Moghaddam, ... Hemoglobin 26 (2), 147-154, 2002 | 80 | 2002 |
Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease MA Khosravi, M Abbasalipour, JP Concordet, J Vom Berg, S Zeinali, ... European journal of pharmacology 854, 398-405, 2019 | 77 | 2019 |
Novel mutations in the BRCA1 and BRCA2genes in Iranian women with early-onset breast cancer VR Yassaee, S Zeinali, I Harirchi, S Jarvandi, MA Mohagheghi, ... Breast Cancer Research 4, 1-6, 2002 | 75 | 2002 |